NASDAQ:BNTX a German company and its american partner NYSE:PFE
will likely have a first-mover advantage in the coronavirus vaccine race in the U.S. This will affect both stocks, once the final vaccine results are in.
Assuming the bottom is in and we are about to continue the Trend as previously, im expecting a big move after the approval, so dont forget to...
Anticipating some positive news from RLFTF's and further FDA approval for it's Aviptadil.
ABCDE Triagle wave approaching completion, confirmed by Williams Alligator, and Fib Retracement
A bounced off 0.382 level
C bounced off 0.5 level
Look for E confirmation off 0.618 level
Should price exit the triangle formation, setting target @ $1.2
The charts are primed for a breakout! Indicators show buy signals on lower timeframes and overbought areas while charts look like forming a double bottom whith huge support at 12.5 usd per share!
Amazing PE Ratio of only 6.78! Forward Dividend & Yield 0.76 (6.10%) ! Soon will enter the China market!
Bayer Says Plans To Submit A New Drug Application For...
We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess?
Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
Good morning, today I present the analysis of PHM, a Spanish company pharmamar in the race for the vaccine against Covid19.
It is being a great trading year for this company.
The bullish structure marked by the yellow arrow has been broken, but the new structure, the bearish one, has not yet consolidated.
You have marked supports and resistances to see possible...
The pharmaceutical sector is one of the most interesting ones in such a troubled period.
I see some growth potential for $ACAD in the short term. It is showing a positive trend that is already consolidated and heading for a possible TP of around 44-45$
I see this level as an important resistance since it has been tested repeatedly in the past.
***As usual, not...
This is a simple support & resistance analysis of this stocks current price level. The stock is at a price level which can be said as a good established support level, the last time the stock was here it was almost 3 months ago and it made good gains after touching this level. If anyone beleives there are other reasons for why this stock will continue to fall...
CRBP Corbus Pharmaceuticals sits at the support level of 2016.
If it doesn`t hold, God knows where it will stop.
On 9/9/2020 HC Wainwright Lower Price Target Buy $24.00 ➝ $6.00, so a 5x from here.
The market cap is low for the industry: 98.872M
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the...
LXXGF LEXAGENE holdings is on a short term downtrend to test the SSSA line on its weekly charts.
Short term target is $0.53. A break of $0.53 below will test $0.30 (All time Lows)
A break above $0.67 will resume its uptrend to test $0.80.
Pivot to the upside is at $0.80 cents for any upside breakout to the highs.
Breaking down through support, this is what kept me out of trading PFE to the long-side even though it looked bullish. With the elections coming up and democrats leading the polls, I'd stay away from pharma and insurers. Lean towards medical devices if you need healthcare exposure.